Aptamer Group and Bio-Works Technologies partner to enable improved solutions for gene therapy manufacturing
York, UK and Uppsala, Sweden (August 25, 2021) Aptamer Group Ltd , the developer of custom affinity tools to enable the life science industry through its proprietary Optimer platform, and Bio-Works Technologies AB , the developer and manufacturer of leading-edge agarose-based purification technologies, today announce that they have entered into an agreement to co-develop a new affinity resin for improved purification and scale up of gene therapy vectors. Under the agreement, Aptamer Group will develop an Optimer™ ligand capable of